Bailard’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,500
Closed -$317K 849
2024
Q3
$317K Sell
27,500
-20,000
-42% -$229K 0.01% 561
2024
Q2
$538K Hold
47,500
0.01% 436
2024
Q1
$680K Sell
47,500
-4,700
-9% -$66.6K 0.02% 391
2023
Q4
$716K Buy
52,200
+33,688
+182% +$355K 0.02% 361
2023
Q3
$151K Buy
+18,512
New +$151K 0.01% 672
2023
Q2
Sell
-21,800
Closed -$174K 798
2023
Q1
$174K Sell
21,800
-31,900
-59% -$328K 0.01% 667
2022
Q4
$610K Buy
53,700
+17,200
+47% +$188K 0.02% 355
2022
Q3
$319K Buy
36,500
+14,500
+66% +$151K 0.01% 448
2022
Q2
$219K Buy
+22,000
New +$221K 0.01% 585

Other funds holding PTVE

Bailard's PTVE Position: Q4 2024 in Review

Bailard sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2024, closing a stake of 27,500 shares — an estimated $317K sold.

Bailard first reported a position in PTVE in Q2 2022 and held it in 9 quarters. The position peaked at $716K in Q4 2023. 161 funds tracked by Wall St. Rank hold PTVE as of Q4 2024.

  • Bailard reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2024 after selling out during the quarter.
  • Bailard sold 27,500 Pactiv Evergreen Inc. Common stock shares in Q4 2024, an estimated $317K.
  • Bailard first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 9 quarters.
  • Bailard's Pactiv Evergreen Inc. Common stock position peaked at $716K in Q4 2023.
  • 161 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2024.

Based on Bailard's 13F filing for Q4 2024, filed 5 Feb 2025.